targeted therapy News

Latest Articles

• U.S. Multiple Myeloma Mortality Rates Plummet Following Adoption of CAR T-Cell and Bispecific Therapies

  Published: Apr 30, 2026

  Section: Medical News

  A comprehensive analysis of U.S. population data from 1975 to 2023 shows a significant decline in multiple myeloma mortality, specifically linked to the introduction of targeted th...

• New Magnetic Microrobotic Control System From University of Essex Promises to Revolutionize Targeted Cancer Therapy Precision

  Published: Apr 29, 2026

  Section: Health Technology

  Engineers at the University of Essex have developed the Tuneable Magnetic End Effector, a sophisticated tool designed to guide medical microrobots through the body with unprecedent...

• UCLA Scientist Dennis Slamon Joins Elite American Physicians Association Following Decades of Breast Cancer Innovation

  Published: Apr 25, 2026

  Section: Medical News

  Dr. Dennis Slamon has been elected to the Association of American Physicians in recognition of his transformative work in oncology. The UCLA professor led the discovery of the HER2...

• Targeted Inhibitors Successfully Resolve Refractory Mixed Histiocytosis Following Multiple Cranial Relapses In Elderly Patient

  Published: Apr 16, 2026

  Section: Health

  A 76-year-old patient diagnosed with a rare combination of Langerhans cell histiocytosis and Erdheim-Chester disease has achieved complete metabolic remission through targeted BRAF...

• University of Geneva Researchers Develop Programmable DNA Drugs That Compute Cancer Signals for Precision Delivery

  Published: Apr 4, 2026

  Section: Research

  Scientists have engineered a "smart" drug system using synthetic DNA strands that functions like a molecular computer to target tumors with extreme accuracy. By requiring a "two-ke...

• Long-Term Clinical Data Reveals Pralsetinib Dramatically Extends Survival for Patients With Advanced RET Fusion Lung Cancer

  Published: Apr 2, 2026

  Section: Medical News

  A 42-month follow-up study of the ARROW clinical trial demonstrates that the targeted therapy pralsetinib increases median survival to 44 months for patients with specific genetic...

• University of Geneva Scientists Develop Programmable DNA Logic Gates to Create Autonomous Self Regulating Cancer Drugs

  Published: Apr 1, 2026

  Section: Science & Tech

  Researchers at the University of Geneva have engineered a molecular system using synthetic DNA strands that acts like a biological computer to neutralize cancer cells. By utilizing...

• Groundbreaking Nature Study Links Male Hormones to Growth of Lethal and Previously Untreatable Pediatric Brain Tumors

  Published: Mar 26, 2026

  Section: Health

  An international research consortium led by Baylor College of Medicine has identified androgens as the primary driver behind Posterior Fossa Type A (PFA) ependymoma, a deadly child...

• Innovative Mini-Antibody "Flashlight" Developed to Illuminate Protein Specific Tumors for Precision Cancer Treatment

  Published: Mar 16, 2026

  Section: Science & Tech

  Biochemists at the University of Missouri have engineered a radioactive mini-antibody that identifies the EphA2 protein in cancer cells, causing tumors to glow during PET scans. Th...